Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
126.13%Gross Profits to Assets
VS
Market
Sector
Industry
History
$ 5.95Close
$ 3.54 - $ 14.85 52-Week Range
Ticker Information
Ticker
KPTICompany Name
KARYOPHARM THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQKARYOPHARM THERAPEUTICS INC - Gross Profits to Assets Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
KPTI - GPA Historical data
| Date | Total Assets | Gross Profit | Gross Profits to Assets |
|---|---|---|---|
| 6/30/2025 | $ 104.88M | $ 132.29M | 126.13% |
| 3/31/2025 | $ 127.71M | $ 136.73M | 107.06% |
| 12/31/2024 | $ 164.42M | $ 139.23M | 84.68% |
| 9/30/2024 | $ 189.48M | $ 142.28M | 75.09% |
| 6/30/2024 | $ 213.98M | $ 139.9M | 65.38% |
| 3/31/2024 | $ 204.46M | $ 134.96M | 66.01% |
| 12/31/2023 | $ 240.44M | $ 141.09M | 58.68% |
| 9/30/2023 | $ 269.96M | $ 140.54M | 52.06% |
| 6/30/2023 | $ 297.83M | $ 140.61M | 47.21% |
| 3/31/2023 | $ 325.8M | $ 142.96M | 43.88% |
Key Performance Insights, Last 5 Years
- KARYOPHARM THERAPEUTICS INC's latest trailing twelve months (TTM) GPA stands at 26.08%.
- Over the past 5 years, KARYOPHARM THERAPEUTICS INC's average GPA has been 64.84%.
- The median GPA for KARYOPHARM THERAPEUTICS INC during this period was 62.03%
- KARYOPHARM THERAPEUTICS INC reached its highest GPA over the past 5 years at 126.13%.
- The lowest GPA recorded by KARYOPHARM THERAPEUTICS INC in the same timeframe 26.08%
KARYOPHARM THERAPEUTICS INC's GPA vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GPA Benchmarks
Similar metrics to GPA:
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
- Asset Turnover - [Calculation] The Asset Turnover ratio measures how effective a company uses its assets to generate revenue. It is calculated as [Revenue] divided by [Assets].
- Current Assets - [Balance Sheet] The current (short-term) portion of [Assets] that are usually convertible to cash within a year; reported if the company operates a classified balance sheet that segments current and non-current assets.
- Gross Profit - [Income Statement] Gross Profit is a financial metric that demonstrates how sales [Revenue] cover the direct costs associated with the production of goods [CoR].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
Definition of Gross Profits to Assets
[Calculation] Gross Profits to Assets (GPA) measures how effective a company leverages its assets to generate gross profits. It is calculated as gross profits [GP] divided by [Assets].GP / Assets
(=) GPA GPA for KARYOPHARM THERAPEUTICS INC is calculated as follows: GP [ $ 88.03M ] / Assets [ $ 337.59M ]
(=) GPA [ 26.08% ] KPTI - Gross Profits to Assets, Last 5 years
26.08%
Minimum
Sep 30, 2020
126.13%
Maximum
Jun 30, 2025
64.84%
Average
62.03%
Median
GPA Benchmark AnalysisMarket
The chart above depicts the distribution of GPA for companies in the Total Stock Market. The average GPA of the companies is 20.16% with a standard deviation of 19.95%.
The following table provides additional summary stats:
GPA in the Market:
| filtered constituents | 4.13K |
|---|---|
| min | -50.32% |
| max | 83.98% |
| average | 20.16% |
| median | 15.35% |
| std | 19.95% |